Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV/HCV co-infection: natural history.
Puoti M, Prestini K, Putzolu V, Zanini B, Baiguera C, Antonini MG, Pagani P, Airoldi M, Carosi G. Puoti M, et al. Among authors: prestini k. J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):144-6. J Biol Regul Homeost Agents. 2003. PMID: 14518713 Review.
[Treatment of HCV infection in HIV-positive patients].
Puoti M, Zanini B, Baiguera C, Bella D, Prestini K, Milesi L, Antonini MG, Carosi G. Puoti M, et al. Among authors: prestini k. Recenti Prog Med. 2001 Oct;92(10):618-23. Recenti Prog Med. 2001. PMID: 11695308 Review. Italian.
HIV-related liver disease: ARV drugs, coinfection, and other risk factors.
Puoti M, Nasta P, Gatti F, Matti A, Prestini K, Biasi L, Carosi G. Puoti M, et al. Among authors: prestini k. J Int Assoc Physicians AIDS Care (Chic). 2009 Jan-Feb;8(1):30-42. doi: 10.1177/1545109708330906. Epub 2009 Feb 11. J Int Assoc Physicians AIDS Care (Chic). 2009. PMID: 19211929 Review.
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
Gatti F, Nasta P, Loregian A, Puoti M, Matti A, Pagni S, de Requena DG, Prestini K, Parisi SG, Bonora S, Palù G, Carosi G. Gatti F, et al. Among authors: prestini k. J Antimicrob Chemother. 2009 Mar;63(3):575-8. doi: 10.1093/jac/dkn525. Epub 2009 Jan 16. J Antimicrob Chemother. 2009. PMID: 19151039
HIV-associated asymmetric lipodystrophy syndrome.
Quiros-Roldan E, Moretti F, Torti C, Casari S, Prestini K, Carosi G. Quiros-Roldan E, et al. Among authors: prestini k. Rev Clin Esp. 2004 Mar;204(3):177. doi: 10.1157/13058836. Rev Clin Esp. 2004. PMID: 15025990 No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.